DalsnaFinance › IPOs › China SXT Pharmaceuticals › IPO
China SXT Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on January 4, 2019, pricing at $4.00 a share.
| Ticker | SXTC |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 4, 2019 |
| Offering price | $4.00 |
| Shares offered | 2,546,275 |
| Total raised | $10M |
China SXT Pharmaceuticals, Inc. sold 2,546,275 shares at $4.00 each on NASDAQ. Multiplied out, that is $10.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $10 million total recorded for the deal.
China SXT Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for China SXT Pharmaceuticals, Inc.. This page is general information, not investment advice.